REVEAL 2 Trial (Evaluation of VGX-3100 and Electroporation for the Treatment of Cervical HSIL)

Clinical trial NCT03721978 · COMPLETED

Trial details

NCT number: NCT03721978
Sponsor: Inovio Pharmaceuticals
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Cervical Dysplasia Cervical High Grade Squamous Intraepithelial Lesion HSIL

Start date: 2019-02-28
Primary completion: 2022-08-23
Enrollment: 203

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.